What most people call 'acne scars' is two distinct conditions with very different treatment pathways. Post-inflammatory hyperpigmentation (PIH) — the flat dark marks that remain after a breakout clears — is discolouration that responds well to topical treatment over three to six months. True atrophic scars — ice pick, boxcar, and rolling depressions — represent structural collagen loss that requires professional procedures to meaningfully improve. Understanding which type you're dealing with is the critical first step.
PIH (flat dark marks) responds well to topical treatment: SPF 50 daily, vitamin C AM, niacinamide 5%, azelaic acid, and AHA exfoliation 2–3× per week. Allow 3–6 months. Atrophic scars (depressions) represent structural tissue loss and cannot be filled by skincare — professional procedures (microneedling, fractional laser, TCA CROSS) are required for meaningful improvement.
PIH is a pigmentation response to inflammation — not a scar in the structural sense. It fades naturally over 6–24 months even without treatment. The right routine accelerates this significantly.
Most PIH fades significantly in 3–6 months with this protocol and strict daily SPF. Deep PIH in darker skin tones may take up to 12 months.
Atrophic scars represent structural tissue loss — collagen destroyed by the inflammatory process of severe acne. Topical actives can improve surrounding skin texture and fade pigmentation within scars, but cannot refill voids. Professional options by scar type:
Clear active acne first — ongoing breakouts continuously create new PIH. Never pick or squeeze, which dramatically worsens both PIH duration and atrophic scar risk. Daily SPF 50. These three steps prevent the situation worsening while treatment addresses what's already there.
Check whether your acne scar routine has the right ingredients working together using Skin Stacker's free stack analyser.
Analyse Your Scar Routine →Post-inflammatory hyperpigmentation does not behave the same way across all skin tones, and the timeline expectations that appear in general skincare advice are often based on research conducted primarily on lighter skin types. Understanding the actual biology matters for setting realistic expectations and choosing the right ingredients.
PIH occurs because inflammation triggers melanocytes to produce excess melanin as a protective response. In darker skin tones (Fitzpatrick types IV–VI), melanocytes are more numerous, more active, and produce a higher-quality, more stable form of melanin — eumelanin — compared to the pheomelanin that predominates in lighter skin. This means PIH in darker skin tones is deeper in colour, slower to fade naturally, and more responsive to melanin-targeting ingredients than to surface exfoliation alone.
Realistic timelines by skin tone: lighter skin (Fitzpatrick I–III) can expect significant PIH fading within three to four months of a consistent topical protocol. Medium to deeper skin tones (Fitzpatrick IV–VI) should plan for six to twelve months, with melasma-type pigmentation potentially requiring twelve to eighteen months of consistent management. This is not a failure of the protocol — it is the biology of melanin production in more melanin-rich skin.
Ingredient priorities shift accordingly. For darker skin tones, azelaic acid (10–20%) and tranexamic acid (2–5%) become higher priorities than glycolic acid, because their mechanisms target the melanocyte directly rather than relying on surface exfoliation that carries PIH risk of its own if it triggers irritation. Mandelic acid is preferred over glycolic as the AHA of choice for the same reason — its larger molecular size and slower penetration dramatically reduce the inflammatory response that could itself cause new PIH.
No single ingredient addresses PIH through every biological pathway simultaneously. The most effective topical protocols work because they combine ingredients that act at different steps of the melanin production and transfer cycle — creating what researchers call a "multi-pathway inhibition" approach.
The melanin pathway has four key intervention points. UV stimulus prevention (SPF 50) stops the external trigger that activates melanocytes every morning. Tyrosinase inhibition (vitamin C, azelaic acid, tranexamic acid, kojic acid) blocks the enzyme that converts tyrosine to melanin at the production stage. Melanin transfer inhibition (niacinamide 5%) prevents melanin packages from moving from melanocytes into surrounding skin cells once produced. Pigmented cell clearance (AHAs: glycolic, lactic) accelerates the shedding of skin cells that already contain melanin, removing the visible pigmentation from the surface.
A routine that addresses only one or two of these pathways will produce partial results. A routine that addresses all four — SPF, tyrosinase inhibitor AM, melanin transfer inhibitor AM and PM, and AHA exfoliation two to three times weekly PM — consistently outperforms any single-ingredient approach in the clinical literature on PIH treatment.
The most important principle in PIH treatment is that every new breakout creates new PIH, and every day of unprotected UV exposure darkens existing marks. Treatment and prevention must happen simultaneously or the protocol is working against itself.
Practical prevention steps that run alongside the treatment protocol:
Absolutely no picking or squeezing. This bears repeating because it is the single most impactful behavioural intervention available. A breakout that resolves naturally leaves PIH that takes months to fade. A breakout that is picked or squeezed leaves PIH that is three to five times darker, seated deeper, and takes proportionally longer to clear — and carries a meaningful risk of converting from flat PIH to atrophic scarring if the dermis is damaged.
Address active acne aggressively. PIH cannot be treated into remission if new spots are continuously appearing. Salicylic acid, benzoyl peroxide, and niacinamide should all be deployed to minimise active breakouts so the depigmenting protocol is working on a stable, not expanding, pigmentation load.
SPF, every day, including cloudy days and indoors. UVA penetrates glass. Sitting near a window for an hour without SPF applies meaningful UV stimulus to facial skin. For active PIH treatment, SPF is not a summer precaution — it is a daily non-negotiable that determines whether the rest of the protocol has any chance of working.
Both — they work at different steps of the same pathway and are best used together. Vitamin C inhibits tyrosinase, preventing new melanin from forming. Niacinamide blocks melanin transfer, preventing already-formed melanin from reaching the skin surface. Used simultaneously (vitamin C AM, niacinamide AM and PM), they address PIH through two independent mechanisms. Research comparing 5% niacinamide to 4% hydroquinone found comparable efficacy for some PIH types — and unlike hydroquinone, niacinamide is safe for indefinite long-term use without the rebound hyperpigmentation risk.
For PIH (flat marks), yes — retinol accelerates cell turnover, which speeds the clearance of pigmented cells from the skin surface. It is a useful addition to a PIH protocol, alternated with AHAs rather than used on the same night. For true atrophic scars (depressions), retinol has modest benefit: it can stimulate some collagen synthesis and improve overall skin texture, which makes shallow boxcar and rolling scars appear less pronounced, but it cannot structurally rebuild the collagen lost in deep scarring.
For PIH that has not meaningfully faded after six months of a consistent, well-formulated topical protocol including daily SPF, a dermatologist can assess whether prescription hydroquinone (4%), tretinoin, or combination therapies (the Kligman formula) are appropriate. For atrophic scarring — ice pick, boxcar, or rolling scars of any meaningful depth — professional procedures are the correct first step, not additional topical products. A single consultation to understand your scar type and the realistic options is time and money well spent.